ABBOTT INDIA
Back to Cashflow Statement
|
ABBOTT INDIA Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-118 Cr | ₹269 Cr | ₹52 Cr | ₹107 Cr | ₹-86 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ABBOTT INDIA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-118 Cr |
| Mar2025 | ₹269 Cr |
| Mar2024 | ₹52 Cr |
| Mar2023 | ₹107 Cr |
| Mar2022 | ₹-86 Cr |
How is Net Cash Inflow / Outflow of ABBOTT INDIA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-118 Cr | Negative | |
| Mar2025 | ₹269 Cr | 416.32 | |
| Mar2024 | ₹52 Cr | -51.32 | |
| Mar2023 | ₹107 Cr | Positive | |
| Mar2022 | ₹-86 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹59,943.4 Cr | 2.3% | 8% | -19.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,375.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹116,447.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,106.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 2.3% |
8% |
-19.4% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses